amUE3CNSrgfNsbYsuwBs1PXOvEvlqrSYZ7J3zx9oqximcai0cfZfJfGA2Gr8
Current position: Home >> Scientific Research >> Paper Publications

Combination treatment of Ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer

Hits:

Institution:药学院

Title of Paper:Combination treatment of Ligustrazine piperazine derivate DLJ14 and adriamycin inhibits progression of resistant breast cancer

Journal:Drug Discovery Therapeutics

First Author:郭秀丽

All the Authors:刘新泳,郭秀丽

Document Code:lw-158888

Volume:8

Issue:1

Page Number:33

Number of Words:5

Translation or Not:No

Date of Publication:2014-03

Release Time:2019-10-24

Prev One:Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats

Next One:DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo